APOE and TREM2 variants differentially influence glial fibrillary acidic protein and neurofilament light in plasma of UK Biobank participants
Freudenberg-Hua, Y.; Giliberto, L.; d'Abramo, C.; Li, W.; Ma, Y.; Goate, A. M.; Koppel, J.
Show abstract
Plasma levels of protein biomarkers glial fibrillary acidic protein (GFAP) and neurofilament light (NEFL) are key dementia biomarkers, but it is unclear how risk genes for Alzheimers disease (AD) influence levels of these biomarkers. We investigated the association of the established high-effect variants for AD in APOE and TREM2 with these biomarkers, using data from over 50,000 participants from the UK Biobank (UKB). The results show that APOE4 is associated with elevated levels of plasma GFAP, and to a lesser extent, NEFL. The APOE4 effect on GFAP increases with age and the number of APOE4 alleles. The risk variants R47H and R62H in TREM2 are associated with higher NEFL levels, but not with GFAP, and the effect sizes do not increase with age. Higher levels of both GFAP and NEFL in midlife are significantly associated with greater risk for incident dementia. In contrast, the protective APOE2 allele showed no effect on GFAP or NEFL. In conclusion, we find that major genetic risk factors for AD differentially affect dementia protein biomarkers across age, indicating gene specific pathways with potential therapeutic implications.
Matching journals
The top 7 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Interrogating the plasma proteome of repetitive head impact exposure and chronic traumatic encephalopathy 96%
- Cerebrospinal fluid total tau levels indicate aberrant neuronal plasticity in Alzheimer’s disease 96%
- Global neuropathologic severity of Alzheimer’s disease and locus coeruleus vulnerability influences plasma phosphorylated tau levels 95%
Similar papers in this journal
- TREM2 Risk Variants with Alzheimer’s Disease Differ in Rate of Cognitive Decline 98%
- Early Syndecan-4 Upregulation Predicts Cognitive and Pathological Trajectories in Alzheimer Disease 96%
- Perivascular space enlargement accelerates with hypertension, white matter hyperintensities, chronic inflammation, and Alzheimer’s disease pathology: evidence from a three-year longitudinal multicentre study 95%
Similar papers in this journal
- Liver-specific polygenic risk score is more strongly associated than genome-wide score with Alzheimer’s disease diagnosis in a case-control analysis 97%
- Effect of Pathway-specific Polygenic Risk Scores for Alzheimer’s Disease (AD) on Rate of Change in Cognitive Function and AD-related Biomarkers among Asymptomatic Individuals 96%
- Inflammation in Alzheimer's disease: do sex and APOE matter? 95%
Similar papers in this journal
- Explainable artificial intelligence identifies an AQP4 polymorphism-based risk score associated with brain amyloid burden 95%
- Vascular risk burden is a key player in the early progression of Alzheimer’s disease 95%
- Mitochondrial pathway polygenic risk scores are associated with Alzheimer's Disease 95%